Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 08:14 am Purchase | 2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | AVORO CAPITAL ADVISORS LLC | 3,232,142 9.090% | 3,232,142 (New Position) | Filing History |
| 2021-02-12 08:14 am Purchase | 2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | AVORO CAPITAL ADVISORS LLC | 2,800,000 8.000% | 400,000 (+16.67%) | Filing History |
| 2021-02-12 08:13 am Sale | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -393,333 (Position Closed) | Filing History |
| 2021-02-12 08:13 am Sale | 2020-12-31 | 13G | Cue Biopharma, Inc. CUE | AVORO CAPITAL ADVISORS LLC | 452,500 1.500% | -1,417,500 (-75.80%) | Filing History |
| 2021-02-12 08:12 am Sale | 2020-12-31 | 13G | Athenex, Inc. ATNX | AVORO CAPITAL ADVISORS LLC | 18,625 0.400% | -244,447 (-92.92%) | Filing History |
| 2021-02-12 08:11 am Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -415,999 (Position Closed) | Filing History |
| 2021-02-12 08:11 am Purchase | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | AVORO CAPITAL ADVISORS LLC | 2,350,267 5.300% | 2,350,267 (New Position) | Filing History |
| 2021-02-12 08:10 am Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | AVORO CAPITAL ADVISORS LLC | 1,000,000 7.100% | 1,000,000 (New Position) | Filing History |
| 2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | AVORO CAPITAL ADVISORS LLC | 5,800,000 5.700% | 5,800,000 (New Position) | Filing History |
| 2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | AVORO CAPITAL ADVISORS LLC | 4,000,000 6.200% | 4,000,000 (New Position) | Filing History |
| 2021-02-12 08:08 am Purchase | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | AVORO CAPITAL ADVISORS LLC | 2,850,000 6.400% | 2,850,000 (New Position) | Filing History |
| 2021-02-12 08:08 am Purchase | 2020-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA | AVORO CAPITAL ADVISORS LLC | 4,190,000 7.200% | 4,190,000 (New Position) | Filing History |
| 2021-02-12 08:07 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | AVORO CAPITAL ADVISORS LLC | 4,365,000 7.500% | 4,365,000 (New Position) | Filing History |
| 2021-02-12 08:06 am Purchase | 2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | AVORO CAPITAL ADVISORS LLC | 1,225,000 7.900% | 1,225,000 (New Position) | Filing History |
| 2021-02-12 08:06 am Purchase | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | AVORO CAPITAL ADVISORS LLC | 7,250,000 8.100% | 7,250,000 (New Position) | Filing History |
| 2021-02-12 08:05 am Purchase | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | AVORO CAPITAL ADVISORS LLC | 1,525,000 9.400% | 1,525,000 (New Position) | Filing History |
| 2021-02-12 08:04 am Purchase | 2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | AVORO CAPITAL ADVISORS LLC | 6,800,000 9.900% | 6,800,000 (New Position) | Filing History |
| 2021-02-12 08:04 am Purchase | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | AVORO CAPITAL ADVISORS LLC | 33,613,444 9.990% | 33,613,444 (New Position) | Filing History |
| 2021-02-12 08:03 am Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | AVORO CAPITAL ADVISORS LLC | 7,500,000 5.100% | -1,326,039 (-15.02%) | Filing History |
| 2021-02-12 08:01 am Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | AVORO CAPITAL ADVISORS LLC | 2,950,000 6.200% | -700,000 (-19.18%) | Filing History |